There is tremendous discussion when it comes to glioblastoma, which is something that very few will be able to argue against. Keep in mind that this is the same condition that Senator Edward Kennedy had before he passed away back in 2009. As one can imagine, this is a serious condition but the fact that it is typically viewed as the most aggressive in the brain speaks volumes, according to the likes of Stuart Millheiser. That being said, what is it that can be said about the vaccine called HSPPC-96 in relation to this condition?
According to an article that was published on News-Medical, an experimental vaccine can potentially become utilized in order to help those with the condition in question. It would include a certain amount of tumor tissue in order to make it impactful. Patients have seen increased levels of survival because of this procedure, which wouldn't have been present with more standard methods. As one can imagine, the results of the phase 2 trial are ones to focus on, seeing as how there is a level of positivity present.
For those who are unfamiliar with glioblastoma, you may be curious as to what makes it so aggressive? The article said that the tumors progress at rapid paces and, because of this, treatment options have limited results. Of course, there are methods that can be taken up, the most common being standard invasive surgery followed by chemotherapy and radiation. However, the long-term results are hard to document, which can be said about conditions like ALS too. This means that more work will be done, as well as seen by the likes of Stuart Millheiser.
The phase 2 trial came into being and it included a total of 41 patients that had tumors in between 2007 and 2011. Each of said patients was given an average of six doses of the vaccine that was given the name of HSPPC-96. The report said that 90 percent of the patients were still alive after six months and 30 percent, after a year. It goes without saying that the work which is rooted in this condition still has to be done. That being said, the potential is something that Stu Millheiser can observe.
Treatment is one of those ideas linked to glioblastoma research that is constantly being worked on. It seems as though treatment in general is one of the broadest areas to consider as well and the fact that there are so many details to consider speaks volumes. Stem cells have been put to use in the past, so the tissue from tumors should be utilized if there are incentives to consider. To me, this goes to show that the degree of potential will prove to be one of the greatest.
According to an article that was published on News-Medical, an experimental vaccine can potentially become utilized in order to help those with the condition in question. It would include a certain amount of tumor tissue in order to make it impactful. Patients have seen increased levels of survival because of this procedure, which wouldn't have been present with more standard methods. As one can imagine, the results of the phase 2 trial are ones to focus on, seeing as how there is a level of positivity present.
For those who are unfamiliar with glioblastoma, you may be curious as to what makes it so aggressive? The article said that the tumors progress at rapid paces and, because of this, treatment options have limited results. Of course, there are methods that can be taken up, the most common being standard invasive surgery followed by chemotherapy and radiation. However, the long-term results are hard to document, which can be said about conditions like ALS too. This means that more work will be done, as well as seen by the likes of Stuart Millheiser.
The phase 2 trial came into being and it included a total of 41 patients that had tumors in between 2007 and 2011. Each of said patients was given an average of six doses of the vaccine that was given the name of HSPPC-96. The report said that 90 percent of the patients were still alive after six months and 30 percent, after a year. It goes without saying that the work which is rooted in this condition still has to be done. That being said, the potential is something that Stu Millheiser can observe.
Treatment is one of those ideas linked to glioblastoma research that is constantly being worked on. It seems as though treatment in general is one of the broadest areas to consider as well and the fact that there are so many details to consider speaks volumes. Stem cells have been put to use in the past, so the tissue from tumors should be utilized if there are incentives to consider. To me, this goes to show that the degree of potential will prove to be one of the greatest.
About the Author:
For additional information in regards to ALS and Stu Millheiser, in general, contact Stuart Millheiser now.. This article, Stuart Millheiser & Discussion About HSPPC-96 is released under a creative commons attribution license.
No comments:
Post a Comment